Amundi Sells 7,355 Shares of Humana Inc. $HUM

Amundi lessened its holdings in shares of Humana Inc. (NYSE:HUM) by 1.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 387,288 shares of the insurance provider’s stock after selling 7,355 shares during the quarter. Amundi owned approximately 0.32% of Humana worth $94,417,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the business. Revolve Wealth Partners LLC acquired a new stake in Humana in the 4th quarter worth about $202,000. LPL Financial LLC increased its holdings in shares of Humana by 7.4% during the first quarter. LPL Financial LLC now owns 35,005 shares of the insurance provider’s stock worth $9,262,000 after purchasing an additional 2,426 shares during the period. Blair William & Co. IL raised its position in shares of Humana by 11.6% in the first quarter. Blair William & Co. IL now owns 4,614 shares of the insurance provider’s stock valued at $1,221,000 after buying an additional 481 shares in the last quarter. Chicago Partners Investment Group LLC bought a new stake in shares of Humana in the first quarter valued at approximately $329,000. Finally, Zions Bancorporation National Association UT acquired a new stake in Humana during the first quarter worth approximately $37,000. 92.38% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. Barclays dropped their price objective on Humana from $245.00 to $234.00 and set an “equal weight” rating for the company in a report on Tuesday, November 25th. Bank of America boosted their price target on Humana from $280.00 to $300.00 and gave the company a “neutral” rating in a research note on Friday, October 10th. Wolfe Research cut their price objective on shares of Humana from $313.00 to $300.00 and set an “outperform” rating for the company in a research report on Thursday, November 20th. Sanford C. Bernstein increased their price objective on shares of Humana from $269.00 to $341.00 and gave the stock an “outperform” rating in a research note on Friday, September 5th. Finally, The Goldman Sachs Group dropped their target price on shares of Humana from $235.00 to $215.00 and set a “sell” rating for the company in a research report on Monday, November 24th. Nine analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, Humana currently has a consensus rating of “Hold” and an average target price of $296.84.

Humana Price Performance

Shares of HUM opened at $257.97 on Monday. The company has a quick ratio of 2.02, a current ratio of 2.02 and a debt-to-equity ratio of 0.68. The stock has a market cap of $31.03 billion, a PE ratio of 24.18, a PEG ratio of 1.51 and a beta of 0.46. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $315.35. The business has a 50-day simple moving average of $262.52 and a two-hundred day simple moving average of $257.33.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share for the quarter, topping the consensus estimate of $2.95 by $0.29. Humana had a return on equity of 12.86% and a net margin of 1.02%.The company had revenue of $32.65 billion for the quarter, compared to analysts’ expectations of $31.99 billion. During the same period in the previous year, the business posted $4.16 earnings per share. The business’s quarterly revenue was up 11.1% compared to the same quarter last year. Analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.4%. The ex-dividend date is Friday, December 26th. Humana’s dividend payout ratio is 33.18%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.